Suppr超能文献

FBW7通过抑制上皮-间质转化增加肝癌细胞的化学敏感性。

FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition.

作者信息

Yu Jun, Zhang Wu, Gao Feng, Liu Yuan-Xing, Chen Zhi-Yun, Cheng Long-Yu, Xie Shang-Fen, Zheng Shu-Sen

机构信息

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine; Key Laboratory of Multi-Organ Transplantation of Ministry of Public Health, Hangzhou 310003, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):184-91. doi: 10.1016/s1499-3872(14)60029-1.

Abstract

BACKGROUND

FBW7 is a tumor suppressor which regulates a network of proteins with central roles in cell division, cell growth and differentiation. This study aimed to evaluate the role of FBW7 in chemosensitivity and epithelial-mesenchymal transition (EMT) in different hepatocellular carcinoma (HCC) cell lines and to investigate the relevant underlying mechanisms.

METHODS

Different human HCC cell lines (Hep3B, Huh-7, and SNU-449) were cultured. The cell viability was evaluated by cell counting kit-8, and FBW7 mRNA transcription and protein expression were quantitated by real-time PCR and Western blotting. Expressions of vimentin (mesenchymal biomarker) and E-cadherin (epithelial biomarker) were evaluated by Western blotting and immunocytochemistry. Cell invasion was assayed by Transwell migration, and FBW7 plasmid or siRNA was used to evaluate the effect of FBW7 overexpression or silencing on cell chemosensitivity.

RESULTS

FBW7 expression affected tumor cell chemosensitivity to doxorubicin and tumor cell invasive capacity in different HCC cell lines. FBW7hi (high FBW7 expression) Hep3B and FBW7mi (median FBW7 expression) Huh-7 cells were more sensitive to doxorubicin and lower in invasive capacity than FBW7lo (low FBW7 expression) SNU-449 cells. Silencing of FBW7 in Huh-7 and Hep3B cells induced the resistance to doxorubicin and enhanced cell invasion, whereas overexpression of FBW7 in SNU-449 cells restored the sensitivity to doxorubicin and significantly reduced invasive capacity. Furthermore, doxorubicin induced EMT toward mesenchyme in HCC cells. Downregulation of FBW7 in Huh-7 and Hep3B cells or upregulation of FBW7 in SNU-449 cells altered the direction of EMT.

CONCLUSIONS

The level of FBW7 expression impacted the tumor resistance to doxorubicin and the invasion capability of HCC cells. FBW7 therefore may be a potential target for the chemotherapy of HCC through the regulation of EMT.

摘要

背景

FBW7是一种肿瘤抑制因子,可调节在细胞分裂、细胞生长和分化中起核心作用的蛋白质网络。本研究旨在评估FBW7在不同肝癌(HCC)细胞系的化疗敏感性和上皮-间质转化(EMT)中的作用,并探讨相关潜在机制。

方法

培养不同的人肝癌细胞系(Hep3B、Huh-7和SNU-449)。通过细胞计数试剂盒-8评估细胞活力,通过实时PCR和蛋白质免疫印迹法定量FBW7 mRNA转录和蛋白质表达。通过蛋白质免疫印迹法和免疫细胞化学评估波形蛋白(间充质生物标志物)和E-钙黏蛋白(上皮生物标志物)的表达。通过Transwell迁移试验检测细胞侵袭能力,并使用FBW7质粒或小干扰RNA(siRNA)评估FBW7过表达或沉默对细胞化疗敏感性的影响。

结果

FBW7表达影响不同肝癌细胞系中肿瘤细胞对阿霉素的化疗敏感性和肿瘤细胞侵袭能力。FBW7高表达(FBW7hi)的Hep3B细胞和FBW7中等表达(FBW7mi)的Huh-7细胞比FBW7低表达(FBW7lo)的SNU-449细胞对阿霉素更敏感,侵袭能力更低。在Huh-7和Hep3B细胞中沉默FBW7可诱导对阿霉素的耐药性并增强细胞侵袭,而在SNU-449细胞中过表达FBW7可恢复对阿霉素的敏感性并显著降低侵袭能力。此外,阿霉素可诱导肝癌细胞向间充质发生EMT。在Huh-7和Hep3B细胞中下调FBW7或在SNU-449细胞中上调FBW7会改变EMT的方向。

结论

FBW7表达水平影响肝癌细胞对阿霉素的耐药性和侵袭能力。因此,FBW7可能通过调节EMT成为肝癌化疗的潜在靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验